A recent PET/dMRI study that included the full spectrum of biomarker-confirmed AD patients showed the presence of amyloid deposition, regardless of tau deposition, was linked to a decrease in both fiber density and cross-section metrics of FBA [34]. The gene discussed is MAPT; the disease is Alzheimer disease.